(R)-(-)-N-(3,5-Dinitrobenzoyl)-a-phenylglycine
CAS: 74927-72-3
Ref. 3D-FD39706
5g | To inquire | ||
10g | To inquire | ||
25g | To inquire | ||
50g | To inquire | ||
100g | To inquire |
Product Information
- (2R)-[(3,5-Dinitrobenzoyl)amino](phenyl)acetic acid
- benzeneacetic acid, alpha-[(3,5-dinitrobenzoyl)amino]-, (alphaR)-
- (2R)-{[(3,5-dinitrophenyl)carbonyl]amino}(phenyl)ethanoate
- (R)-(− )-N-(3,5-Dinitrobenzoyl)-α-phenylglycine
(R)-(-)-N-(3,5-Dinitrobenzoyl)-a-phenylglycine ((R)-DBBG) is a chiral molecule that is used as an anthelmintic drug. It is a derivative of the amino acid glycine and has been shown to inhibit angiogenesis in cancerous tumors. (R)-DBBG inhibits fatty acid synthesis by binding to the acyl carrier protein and inhibiting the conversion of acetate to malonyl coenzyme A. This inhibition leads to a depletion of long-chain fatty acids, which can be detected by chromatography. The enantiomers have been shown to have different effects on rat liver microsomes, with one enantiomer being more potent than the other. The kinetic studies show that the amines react with R-DBBG and form an intermediate with a reactive α1-acid glycoprotein, which subsequently reacts with hydrogen peroxide and forms a reactive intermediate that decom
Chemical properties
Technical inquiry about: 3D-FD39706 (R)-(-)-N-(3,5-Dinitrobenzoyl)-a-phenylglycine
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.